Pages

Thursday, June 15, 2023

'Targeted & immunotherapy combination has demonstrated improved survival in RCC' https://ift.tt/0WtpNTc

World Kidney Cancer Day: Renal cell carcinoma (RCC) is generally resistant to traditional chemotherapy and radiation therapy. It is crucial that patients with advanced or metastatic kidney cancer receive systemic therapy that includes targeted therapy and immunotherapy.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/nZlHkmD

No comments:

Post a Comment